183 related articles for article (PubMed ID: 24041801)
1. Flow cytometric analysis for detection of tumor-initiating cells in feline mammary carcinoma cell lines.
Michishita M; Otsuka A; Nakahira R; Nakagawa T; Sasaki N; Arai T; Takahashi K
Vet Immunol Immunopathol; 2013 Nov; 156(1-2):73-81. PubMed ID: 24041801
[TBL] [Abstract][Full Text] [Related]
2. Aldehyde dehydrogenase activity in cancer stem cells from canine mammary carcinoma cell lines.
Michishita M; Akiyoshi R; Suemizu H; Nakagawa T; Sasaki N; Takemitsu H; Arai T; Takahashi K
Vet J; 2012 Aug; 193(2):508-13. PubMed ID: 22326935
[TBL] [Abstract][Full Text] [Related]
3. Isolation of stem-like cells from spontaneous feline mammary carcinomas: phenotypic characterization and tumorigenic potential.
Barbieri F; Wurth R; Ratto A; Campanella C; Vito G; Thellung S; Daga A; Cilli M; Ferrari A; Florio T
Exp Cell Res; 2012 Apr; 318(7):847-60. PubMed ID: 22366263
[TBL] [Abstract][Full Text] [Related]
4. ALDH/CD44 identifies uniquely tumorigenic cancer stem cells in salivary gland mucoepidermoid carcinomas.
Adams A; Warner K; Pearson AT; Zhang Z; Kim HS; Mochizuki D; Basura G; Helman J; Mantesso A; Castilho RM; Wicha MS; Nör JE
Oncotarget; 2015 Sep; 6(29):26633-50. PubMed ID: 26449187
[TBL] [Abstract][Full Text] [Related]
5. Organotypic culture of normal, dysplastic and squamous cell carcinoma-derived oral cell lines reveals loss of spatial regulation of CD44 and p75 NTR in malignancy.
Dalley AJ; AbdulMajeed AA; Upton Z; Farah CS
J Oral Pathol Med; 2013 Jan; 42(1):37-46. PubMed ID: 22643025
[TBL] [Abstract][Full Text] [Related]
6. ALDH(+)/CD44(+)/CD24(-) expression in cells from body cavity fluids.
Krishan A; Sharma D; Sharma S; Hamelik RM; Ganjei-Azar P; Nadji M
Cytometry B Clin Cytom; 2010 May; 78(3):176-82. PubMed ID: 20043317
[TBL] [Abstract][Full Text] [Related]
7. Semi-quantitative evaluation of CD44(+) /CD24(-) tumor cell distribution in breast cancer tissue using a newly developed fluorescence immunohistochemical staining method.
Kai M; Onishi H; Souzaki M; Tanaka H; Kubo M; Tanaka M; Katano M
Cancer Sci; 2011 Dec; 102(12):2132-8. PubMed ID: 21838786
[TBL] [Abstract][Full Text] [Related]
8. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.
Kim MP; Fleming JB; Wang H; Abbruzzese JL; Choi W; Kopetz S; McConkey DJ; Evans DB; Gallick GE
PLoS One; 2011; 6(6):e20636. PubMed ID: 21695188
[TBL] [Abstract][Full Text] [Related]
9. Identification of tumor-initiating cells in a canine hepatocellular carcinoma cell line.
Michishita M; Ezaki S; Ogihara K; Naya Y; Azakami D; Nakagawa T; Sasaki N; Arai T; Shida T; Takahashi K
Res Vet Sci; 2014 Apr; 96(2):315-22. PubMed ID: 24534130
[TBL] [Abstract][Full Text] [Related]
10. Preferential killing of breast tumor initiating cells by N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine/tesmilifene.
Deng T; Liu JC; Pritchard KI; Eisen A; Zacksenhaus E
Clin Cancer Res; 2009 Jan; 15(1):119-30. PubMed ID: 19118039
[TBL] [Abstract][Full Text] [Related]
11. Canine mammary tumors contain cancer stem-like cells and form spheroids with an embryonic stem cell signature.
Ferletta M; Grawé J; Hellmén E
Int J Dev Biol; 2011; 55(7-9):791-9. PubMed ID: 22161835
[TBL] [Abstract][Full Text] [Related]
12. In vitro enrichment of tumor-initiating cells from human established cell lines.
Benayoun L; Shaked Y
Curr Protoc Stem Cell Biol; 2013 Feb; Chapter 3():Unit 3.7. PubMed ID: 23404675
[TBL] [Abstract][Full Text] [Related]
13. ALDH activity indicates increased tumorigenic cells, but not cancer stem cells, in prostate cancer cell lines.
Yu C; Yao Z; Dai J; Zhang H; Escara-Wilke J; Zhang X; Keller ET
In Vivo; 2011; 25(1):69-76. PubMed ID: 21282737
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of aldehyde dehydrogenase expression in lung cancer cell lines is revealed by Aldefluor flow cytometry-based assay.
Moreb JS; Zucali JR; Ostmark B; Benson NA
Cytometry B Clin Cytom; 2007 Jul; 72(4):281-9. PubMed ID: 17111384
[TBL] [Abstract][Full Text] [Related]
15. Characterization of spheres derived from canine mammary gland adenocarcinoma cell lines.
Michishita M; Akiyoshi R; Yoshimura H; Katsumoto T; Ichikawa H; Ohkusu-Tsukada K; Nakagawa T; Sasaki N; Takahashi K
Res Vet Sci; 2011 Oct; 91(2):254-60. PubMed ID: 21190702
[TBL] [Abstract][Full Text] [Related]
16. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH
Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433
[TBL] [Abstract][Full Text] [Related]
17. A novel mouse model of human breast cancer stem-like cells with high CD44+CD24-/lower phenotype metastasis to human bone.
Ling LJ; Wang S; Liu XA; Shen EC; Ding Q; Lu C; Xu J; Cao QH; Zhu HQ; Wang F
Chin Med J (Engl); 2008 Oct; 121(20):1980-6. PubMed ID: 19080260
[TBL] [Abstract][Full Text] [Related]
18. Proteolysis-a characteristic of tumor-initiating cells in murine metastatic breast cancer.
Hillebrand LE; Bengsch F; Hochrein J; Hülsdünker J; Bender J; Follo M; Busch H; Boerries M; Reinheckel T
Oncotarget; 2016 Sep; 7(36):58244-58260. PubMed ID: 27542270
[TBL] [Abstract][Full Text] [Related]
19. Identification of brain tumour initiating cells using the stem cell marker aldehyde dehydrogenase.
Choi SA; Lee JY; Phi JH; Wang KC; Park CK; Park SH; Kim SK
Eur J Cancer; 2014 Jan; 50(1):137-49. PubMed ID: 24103144
[TBL] [Abstract][Full Text] [Related]
20. STAT3 as a potential therapeutic target in ALDH+ and CD44+/CD24+ stem cell-like pancreatic cancer cells.
Lin L; Jou D; Wang Y; Ma H; Liu T; Fuchs J; Li PK; Lü J; Li C; Lin J
Int J Oncol; 2016 Dec; 49(6):2265-2274. PubMed ID: 27748818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]